Navigation Links
Isis Reports Financial Results and Highlights for First Quarter 2013
Date:5/7/2013

its partners in the first quarter.

Balance SheetAs of March 31, 2013, Isis had cash, cash equivalents and short-term investments of $371.9 million compared to $374.4 million at December 31, 2012 and had working capital of $361.5 million at March 31, 2013 compared to $349.1 million at December 31, 2012.  Isis maintained its cash position primarily due to the $32.5 million in milestone payments it received in the first quarter while continuing to invest in its pipeline. Isis' cash at March 31, 2013 does not include the $30 million upfront payment Isis received from Roche for Isis' HTT collaboration.  Isis' working capital increased in 2013 primarily due to an increase in current assets resulting from an increase in Isis' investment in Regulus. At March 31, 2013, the carrying value of Isis' investment in Regulus was $44.9 million compared to $33.6 million at December 31, 2012.

Business Highlights"We have had a number of important accomplishments already this year.  Together with Genzyme we brought KYNAMRO to the market in the United States for patients with HoFH.  We continued to mature and expand our severe and rare disease franchise, reporting early encouraging data on our first splicing drug, ISIS-SMNRx, in children with spinal muscular atrophy and initiating Phase 2/3 programs for ISIS-SMNRx with Biogen Idec and ISIS-TTRRx with GSK.  We plan to continue this momentum through the year.  Over the next couple of months we plan to report Phase 2 data on both ISIS-CRPRx and ISIS-APOCIIIRx," continued Ms. Parshall. 

"We continue to be successful in implementing our business strategy and establishing strategic partnerships that provide us with significant value.  The performance of our drugs in the clinic and the broad applicability of our antisense technology have generated significant interest in Isis.  One of our partnering goals is to selec
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Perrigo Reports Record Revenue and Adjusted Earnings
2. Discovery Labs Reports First Quarter 2013 Financial Results
3. Endo Reports First Quarter Financial Results
4. Landauer, Inc. Reports Fiscal 2013 Second Quarter Results
5. Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2013
6. Soligenix Reports First Quarter 2013 Financial Results and Highlights Recent Accomplishments
7. IRIDEX Reports 2013 First Quarter Results
8. Masimo Reports First Quarter 2013 Financial Results
9. Neurocrine Biosciences Reports First Quarter 2013 Results
10. Arena Pharmaceuticals Provides Corporate Update and Reports First Quarter 2013 Financial Results
11. Mylan Reports a 19% Increase in First Quarter 2013 Adjusted Diluted EPS to $0.62
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... , July 22, 2014 The steady ... is spreading to previously rep-friendly specialties, according to ... and marketing consulting firm ZS Associates.      ... 200 U.S. pharmaceutical sales teams. The report examines ... meet with the pharmaceutical sales reps who visit ...
(Date:7/22/2014)... 22, 2014 BioDelivery Sciences International, Inc. (BDSI) ... of Directors has appointed Charles J. (Chuck) Bramlage ... members of the Board.  Mr. Bramlage ... in marketing, sales and other commercial functions.  He is ... a development stage company that was recently acquired by ...
(Date:7/22/2014)... 22, 2014  UL (Underwriters Laboratories), a global ... Food and Drug Administration (FDA) has recognized two ... medical devices incorporating lithium or nickel-based batteries. The ... Household and Commercial Batteries, and UL 1642 - ... Consensus standards are standards recognized by the FDA ...
Breaking Medicine Technology:Even traditionally rep-friendly specialists will see fewer pharmaceutical sales reps this year, according to ZS Associates 2Even traditionally rep-friendly specialists will see fewer pharmaceutical sales reps this year, according to ZS Associates 3Even traditionally rep-friendly specialists will see fewer pharmaceutical sales reps this year, according to ZS Associates 4Even traditionally rep-friendly specialists will see fewer pharmaceutical sales reps this year, according to ZS Associates 5BioDelivery Sciences Appoints Charles J. Bramlage and Dr. Barry I. Feinberg to its Board of Directors 2BioDelivery Sciences Appoints Charles J. Bramlage and Dr. Barry I. Feinberg to its Board of Directors 3BioDelivery Sciences Appoints Charles J. Bramlage and Dr. Barry I. Feinberg to its Board of Directors 4BioDelivery Sciences Appoints Charles J. Bramlage and Dr. Barry I. Feinberg to its Board of Directors 5BioDelivery Sciences Appoints Charles J. Bramlage and Dr. Barry I. Feinberg to its Board of Directors 6BioDelivery Sciences Appoints Charles J. Bramlage and Dr. Barry I. Feinberg to its Board of Directors 7Two UL Battery Safety Standards Are now FDA Recognized Consensus Standards for Medical Devices 2
... , RYE, N.Y., Oct. 14 Curemark, LLC, a drug ... diseases, announced that it has enrolled the first patients in ... The first clinical trial patients have been enrolled at Lake ... trial sites with a total 170 children across the country. ...
... Inc. (Nasdaq: VSCP ), a leading provider of quantitative ... the company,s chief business and financial officer, will be presenting ... Bio Investor Forum in San Francisco, California. Ms. Henderson is ... October 29, 2009 at the Palace Hotel, San Francisco. , ...
Cached Medicine Technology:Curemark Enrolls First Patients in Phase III Clinical Trials for Autism Treatment 2VirtualScopics to Present at the 8th Annual Bio Investor Forum 2
(Date:7/22/2014)... Today, Therapy Changes announces the start of their Teen ... help increase their knowledge and ability to cope with life’s ... to make healthy and positive decisions while connecting with like-minded ... but also a time of major life transition and stress,” ... . , “Teens can at times feel misunderstood, so rather ...
(Date:7/22/2014)... Quebec (PRWEB) July 22, 2014 ... is a set of simple tools, designed to help ... have little or no experience with biofeedback. The tools ... stressful situations and elucidate any abnormal patterns to teach ... today’s fast paced world, we are familiar with stress ...
(Date:7/22/2014)... Mass. (PRWEB) July 22, 2014 ... EBSCO Information Services , announces the launch ... assist occupational health and safety professionals employed by ... chemicals and need to manage the impact of ... PoisonEXPERT provides access to relevant chemical-specific information and ...
(Date:7/22/2014)... (PRWEB) July 22, 2014 The Muscular Dystrophy ... the third annual MUSCLE UP campaign that will ... more than one million Americans fighting muscle disease. ... to visit participating Jiffy Lube service centers through Sept. 1, ... to continue to make progress in the fight for muscle ...
(Date:7/22/2014)... (PRWEB) July 22, 2014 Brand ... landed MediaSource as a Ragan Communications 2014 Health ... will be the second consecutive year that MediaSource placed ... which was awarded to the winning MediaSource team last ... to keep this title against three other contenders that ...
Breaking Medicine News(10 mins):Health News:Therapy Changes Announces Teen Support Group Therapy 2Health News:Thought Technology to Present Software for Stress Control at the 2014 American Psychological Association Convention in DC 2Health News:Thought Technology to Present Software for Stress Control at the 2014 American Psychological Association Convention in DC 3Health News:PoisonEXPERT™ from ExPub Now Available 2Health News:PoisonEXPERT™ from ExPub Now Available 3Health News:Jiffy Lube® Supports Fight Against Muscle Disease with Third Annual MUSCLE UP® Campaign 2Health News:Jiffy Lube® Supports Fight Against Muscle Disease with Third Annual MUSCLE UP® Campaign 3Health News:MediaSource Brand Journalism Returns to Best Health Care Agency Competition in Ragan Communications Health Care Awards 2Health News:MediaSource Brand Journalism Returns to Best Health Care Agency Competition in Ragan Communications Health Care Awards 3
... to Serve Elective Cash Pay ... ... financial services for elective (cash pay) surgery, today,announced a leap forward in ... for bariatric surgeons, cash pay business.,Beginning July 1st, 2008, the BLISCare(SM) insurance ...
... chemotherapeutic agents remains a large problem. In some cases, ... cellular process known as translation, which is central to ... Pelletier and colleagues, at McGill University, Montreal, have identified ... cancer cells to standard anticancer chemotherapeutic agents. , In ...
... a healthier life, study finds , , THURSDAY, June 12 ... aging, a new study found. , Researchers at the ... 60 and older for use of sleeping aids, daytime ... quality, and sleep duration. Based on the results, 20.8 ...
... FDA on food safety , , THURSDAY, June 12 (HealthDay ... ongoing outbreak of salmonella-contaminated tomatoes has risen to 228 ... reported Thursday. , Also Thursday, Congressional investigators said the ... its own stated goals of protecting the nation,s food ...
... Pa., June 12 MEDRAD, INC., has ... PETNET Solutions,a fully owned subsidiary of Siemens ... health care providers to inject Fluorodeoxyglucose,(FDG) for ... an innovative, new way. The partnership will ...
... of Excellence (CCE), the,nation,s only practice-owned and physician ... slate and Board of Directors.,Effective immediately, J. Ike ... the interim President of CCE. In addition, Linda,Bosserman, ... Medical,Officer. Dr. Bosserman had previously served as CCE,s ...
Cached Medicine News:Health News:BLIS to Offer Coverage Through 'A' Rated Insurance Carrier 2Health News:BLIS to Offer Coverage Through 'A' Rated Insurance Carrier 3Health News:Better Sleepers Are 'Successful Agers' 2Health News:228 People in 22 States Sickened in Ongoing Salmonella-Tomato Outbreak 2Health News:228 People in 22 States Sickened in Ongoing Salmonella-Tomato Outbreak 3Health News:228 People in 22 States Sickened in Ongoing Salmonella-Tomato Outbreak 4Health News:228 People in 22 States Sickened in Ongoing Salmonella-Tomato Outbreak 5Health News:MEDRAD and PETNET Solutions Partner for Innovative FDG Delivery 2Health News:MEDRAD and PETNET Solutions Partner for Innovative FDG Delivery 3Health News:Cancer Clinics of Excellence (CCE) Announces Management and Board of Directors Slate at 1st Annual General Membership Meeting 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: